ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.

Also called NCT01694563

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 365 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01694563
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01694563. Allocation not applicable; no masking; primary purpose treatment. Start 2012-09 (actual); primary completion 2017-10-23 (actual). Results posted on 2019-09-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
Acronym
ABLATE-PAS
Condition
Persistent Atrial Fibrillation
Condition
Longstanding Persistent Atrial Fibrillation
Intervention (Device)
Synergy Ablation System
Lead sponsor
AtriCure, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01694563
Content hash
ef49d896fa4e7d3c99c8d6142bd61374de4268c010e712a15a38c9572150671d